Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.35
0.00 (0.00%)
At close: Feb 6, 2026, 4:00 PM EST
8.19
-0.16 (-1.92%)
After-hours: Feb 6, 2026, 5:45 PM EST

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
278821073490-
Market Cap Growth
245.28%-23.38%212.54%-61.94%--
Enterprise Value
278808525109-
Last Close Price
8.353.915.761.925.38-
PS Ratio
3.241.461.350.461.42-
PB Ratio
8.504.075.242.012.13-
P/TBV Ratio
--1692.20-3.04-
P/FCF Ratio
--20.35---
P/OCF Ratio
--20.35---
EV/Sales Ratio
4.681.431.070.331.73-
EV/EBITDA Ratio
--17.57---
EV/EBIT Ratio
--79.43---
EV/FCF Ratio
--16.22---
Debt / Equity Ratio
0.981.280.871.570.221.76
Debt / EBITDA Ratio
--3.59--1.93
Debt / FCF Ratio
--3.38--3.52
Asset Turnover
0.800.720.870.730.851.04
Inventory Turnover
1.711.701.882.564.5412.91
Quick Ratio
1.080.871.020.901.401.15
Current Ratio
1.421.371.351.161.641.26
Return on Equity (ROE)
-47.05%-72.60%-20.64%-100.39%-168.12%81.00%
Return on Assets (ROA)
-4.60%-10.88%0.73%-16.99%-15.79%11.44%
Return on Invested Capital (ROIC)
-21.77%-75.75%9.62%-404.39%-170.38%40.91%
Return on Capital Employed (ROCE)
-12.10%-30.30%3.10%-71.80%-41.30%32.90%
Earnings Yield
-3.12%-17.96%-3.61%-86.86%-49.09%-
FCF Yield
-1.42%-11.17%4.92%-39.68%-2.43%-
Buyback Yield / Dilution
-16.55%-12.06%-4.00%-72.05%5.96%-7.55%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q